Parabolin
Parabolin Brand names, Parabolin Analogs
- Adiposon
- Amfepramon
- Amfepramone
- Amfepramone HCL
- Amfepramone Hydrochloride
- Amfepramonum [INN-Latin]
- Amphepramon
- Amphepramone
- Amphepramonum hydrochloride
- Anfamon
- Anfepramona [INN-Spanish]
- Anorex
- Cegramine
- DEA No. 1610
- Danylen
- Derfon
- Diethylpropion HCL
- Diethylpropion Hydrochloride
- Diethylpropione
- Diethylpropione hydrochloride
- Dobesin
- Frekentine
- Keramik
- Keramin
- Magrene
- Moderatan
- Modulor
- Neobes
- Nopropiophenone
- Obesitex
- Parabolin
- Prefamone
- Regenon
- Regenon hydrochloride
- Reginon
- Silutin
- Tenuate
- Tenuate Dospan
- Tenuate hydrochloride
- Tepanil
- Tepanil Ten-tab
- Tylinal
- alpha-Benzoyltriethylamine
- alpha-Diethylaminopropiophenone
Parabolin Brand Names Mixture
- No information avaliable
Parabolin Chemical_Formula
C13H19NO
Parabolin RX_link
http://www.rxlist.com/cgi/generic3/diethprop.htm
Parabolin fda sheet
Parabolin msds (material safety sheet)
Parabolin Synthesis Reference
No information avaliable
Parabolin Molecular Weight
205.296 g/mol
Parabolin Melting Point
No information avaliable
Parabolin H2O Solubility
No information avaliable
Parabolin State
No information avaliable
Parabolin LogP
2.951
Parabolin Dosage Forms
25 mg tablets and 75 mg controlled-release tablets.
Parabolin Indication
Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
Parabolin Pharmacology
Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine.
Parabolin Absorption
Diethylpropion is rapidly absorbed from the GI tract after oral administration.
Parabolin side effects and Toxicity
The reported oral LD50 for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg. Manifestation of acute overdosage include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, and panic states.
Parabolin Patient Information
No information avaliable
Parabolin Organisms Affected
Humans and other mammals
